Thai FDA confirms recalled eye drops in the U.S. are not sold in Thailand
The Food and Drug Administration (FDA) has provided important information to the public following reports that the U.S. Food and Drug Administration (US FDA) has issued a recall for Prednisolone Acetate Ophthalmic Suspension eye drops, manufactured by Lupin in India, due to manufacturing issues that could affect user safety.
Following a thorough investigation by the Thai FDA, it was found that the problematic eye drop product has not been registered and is not imported for sale in Thailand. Therefore, Thai consumers can be confident that this specific batch of affected medication is not available in pharmacies or hospitals within the country.
However, the FDA emphasizes that the public should purchase medication only from licensed pharmacies and always check the drug label clearly before buying. If you encounter any suspicious medical products or suspect they are counterfeit, you can report them via the FDA hotline at 1556 so that officials can take legal action accordingly.
Monitoring the safety of health products is a key mission of the FDA to prevent substandard drugs or products from entering the Thai market. For those who wish to stay informed about health product safety news, updates can be checked regularly through the Food and Drug Administration's website.